




Searching News Database: Advent Life Sciences
HSMN NewsFeed - 2 Sep 2021
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
HSMN NewsFeed - 21 Dec 2015
Axonics Modulation Technologies Announces $38.5 Million Series B Financing
Axonics Modulation Technologies Announces $38.5 Million Series B Financing
HSMN NewsFeed - 28 Oct 2014
Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund
Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund